Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.1
4.9
Journals
IJMS
Special Issues
Venous Thromboembolism, Coagulation, Metabolism and Cancer
ijms-logo
Submit to IJMS Review for IJMS Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Venous Thromboembolism, Coagulation, Metabolism and Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".

Deadline for manuscript submissions: closed (30 October 2022) | Viewed by 4424

Special Issue Editors

Prof. Dr. Antonino Tuttolomondo

E-Mail Website
Guest Editor
1. Internal Medicine and Stroke Care Ward, Policlinico P. Giaccone, Palermo, Italy
2. ProMISE Department, University of Palermo, Palermo, Italy
Interests: ischemic stroke in diabetes; diabetic foot; Anderson-Fabry disease; cytokines
Special Issues, Collections and Topics in MDPI journals
Dr. Vittoriano Della Corte

E-Mail Website
Co-Guest Editor
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy
Interests: vascular ultrasound; echocolordoppler; atherosclerosis; venous thrombosis

Special Issue Information

Dear Colleagues,

Despite advances in research, venous thromboembolism (VTE) continues to be a significant burden for public health.A large body of literature has confirmed the link between VTE and cancer. However, the specific mechanisms leading to abnormalities in Virchow’s triad in cancer patients, particularly the effect on the host haemostatic system to promote the prothrombotic state, are not well understood. They may be tumour-specific, as different cancer types have varying risk rates for cancer-associated thrombosis. An increased risk of VTE has also been observed in metabolic disorders such as diabetes mellitus or metabolic syndrome, but the exact pathophysiological process underlying this association is still unclear.The application of metabolomics profiling in the area of vascular diseases may become a turning point in early diagnosis and patient management.The term ‘metabolomics’ refers to the comprehensive and systematic profiling of all low-molecular-weight compounds which are intermediate or final products of metabolism (e.g., carnitine, phenylalanine, 3-hydroxybutarate and many others) generated as a product of biochemical and physiological processes in the body and present in differential abundance in biofluids, cells and tissues. Despite the latest discoveries we still do not understand the mechanisms and pathways responsible for the occurrence of the observed alterations.This Special Issue attempts to explore the recent advances in venous thromboembolism.

This Special Issue welcomes original research and review papers that further clarify the link between VTE, cancer, metabolic alterations and the aspects concerning the metabolomics of VTE.

Prof. Dr. Antonino Tuttolomondo
Dr. Vittoriano Della Corte
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 5223 KiB  
Article
Monoglyceride Lipase Deficiency Is Associated with Altered Thrombogenesis in Mice
by Madeleine Goeritzer, Katharina B. Kuentzel, Sarah Beck, Melanie Korbelius, Silvia Rainer, Ivan Bradić, Dagmar Kolb, Marion Mussbacher, Waltraud C. Schrottmaier, Alice Assinger, Axel Schlagenhauf, René Rost, Benjamin Gottschalk, Thomas O. Eichmann, Thomas Züllig, Wolfgang F. Graier, Nemanja Vujić and Dagmar Kratky
Int. J. Mol. Sci. 2023, 24(4), 3116; https://doi.org/10.3390/ijms24043116 - 4 Feb 2023
Viewed by 2002
Abstract
Monoglyceride lipase (MGL) hydrolyzes monoacylglycerols (MG) to glycerol and one fatty acid. Among the various MG species, MGL also degrades 2-arachidonoylglycerol, the most abundant endocannabinoid and potent activator of the cannabinoid receptors 1 and 2. We investigated the consequences of MGL deficiency on [...] Read more.
Monoglyceride lipase (MGL) hydrolyzes monoacylglycerols (MG) to glycerol and one fatty acid. Among the various MG species, MGL also degrades 2-arachidonoylglycerol, the most abundant endocannabinoid and potent activator of the cannabinoid receptors 1 and 2. We investigated the consequences of MGL deficiency on platelet function using systemic (Mgl−/−) and platelet-specific Mgl-deficient (platMgl−/−) mice. Despite comparable platelet morphology, loss of MGL was associated with decreased platelet aggregation and reduced response to collagen activation. This was reflected by reduced thrombus formation in vitro, accompanied by a longer bleeding time and a higher blood volume loss. Occlusion time after FeCl3-induced injury was markedly reduced in Mgl−/− mice, which is consistent with contraction of large aggregates and fewer small aggregates in vitro. The absence of any functional changes in platelets from platMgl−/− mice is in accordance with lipid degradation products or other molecules in the circulation, rather than platelet-specific effects, being responsible for the observed alterations in Mgl−/− mice. We conclude that genetic deletion of MGL is associated with altered thrombogenesis. Full article
(This article belongs to the Special Issue Venous Thromboembolism, Coagulation, Metabolism and Cancer)
►▼ Show Figures

Graphical abstract

Review

Jump to: Research

15 pages, 985 KiB  
Review
The Role of Biomarkers, Metabolomics, and COVID-19 in Venous Thromboembolism—A Review of Literature
by Vittoriano Della Corte, Renata Riolo, Stefania Scaglione, Rosaria Pecoraro and Antonino Tuttolomondo
Int. J. Mol. Sci. 2023, 24(17), 13411; https://doi.org/10.3390/ijms241713411 - 29 Aug 2023
Cited by 4 | Viewed by 1914
Abstract
In recent years, the field of venous thromboembolism has undergone numerous innovations, starting from the recent discoveries on the role of biomarkers, passing through the role of metabolomics in expanding our knowledge on pathogenic mechanisms, which have opened up new therapeutic targets. A [...] Read more.
In recent years, the field of venous thromboembolism has undergone numerous innovations, starting from the recent discoveries on the role of biomarkers, passing through the role of metabolomics in expanding our knowledge on pathogenic mechanisms, which have opened up new therapeutic targets. A variety of studies have contributed to characterizing the metabolic phenotype that occurs in venous thromboembolism, identifying numerous pathways that are altered in this setting. Among these pathways are the metabolism of carnitine, tryptophan, purine, and fatty acids. Furthermore, new evidence has emerged with the recent COVID-19 pandemic. Hypercoagulability phenomena induced by this viral infection appear to be related to altered von Willebrand factor activity, alteration of the renin–angiotensin–aldosterone system, and dysregulation of both innate and adaptive immunity. This is the first literature review that brings together the most recent evidence regarding biomarkers, metabolomics, and COVID-19 in the field of venous thromboembolism, while also mentioning current therapeutic protocols. Full article
(This article belongs to the Special Issue Venous Thromboembolism, Coagulation, Metabolism and Cancer)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop